Neonatal lupus is not true lupus. It is a rare condition associated with anti-SSA/Ro and/or anti-SSB/La antibodies from the mother that affect the fetus. At birth, the baby may have a skin rash, liver ...

Understanding the Context

The baby was diagnosed with neonatal lupus erythematosus (NLE). A skin biopsy taken from her back revealed interface dermatitis with dyskeratosis and increased dermal mucin. Echocardiogram and ECG ... Nature: Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study Neonatal lupus erythematosus (NLE) was likely first reported in 1928 in two siblings with congenital heart block (CHB) born to a mother with Sjogren's syndrome (Aylward, 1928).

Key Insights

In 1954, McCuistion and ... Neonatal lupus is a condition diagnosed in fetuses (during pregnancy) and infants (soon after birth). It typically causes temporary and harmless changes, like a skin rash, that go away within a year. Neonatal lupus (NL) is a passively acquired autoimmune disease in the fetus and neonate that is associated with the placental transfer of maternal anti-Ro/SSA and La/SSB autoantibodies. The major manifestations are cardiac and cutaneous findings.

Final Thoughts

What is neonatal lupus? Neonatal lupus is not true lupus. It is a rare condition associated with anti-SSA/Ro and/or anti-SSB/La antibodies from the mother that affect the fetus. At birth, the baby may have a skin rash, liver problems, or low blood cell counts, but these symptoms typically disappear completely after six months with no lasting ... What is neonatal lupus erythematosus? Neonatal lupus erythematosus (LE) is a rare immune-mediated disease particularly affecting the skin and/or heart of a newborn baby with a mother positive for anti-SSA (Ro), anti-SSB (La), or anti-U1RNP antibodies.

This review aims to summarize the epidemiology, pathogenesis, clinical features, management, prognosis and regression of Neonatal lupus erythematosus (NLE) with a view to providing directions for standardized diagnosis, treatment and further ... An infant is diagnosed with neonatal lupus if maternal antibodies, anti-Ro/SSA, anti-La/SSB, or less commonly anti-ribonucleoprotein, are present and if any of the clinical manifestations are present without any other explanation. Neonatal lupus is a passively acquired autoimmune disease that occurs in offspring of mothers with anti-SSA/Ro and/or anti-SSB/La antibodies.